<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28729/isatuximab-as-a-treatment-option-for-mm?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Isatuximab as a Treatment Option for MM

Name: Isatuximab as a Treatment Option for MM
Uploaded: 2019-07-01T06:43:52
Duration: 1 min 27 s
Description: Paul Richardson, MD, Clinical Program Leader, Director of Clinical Research, Jerome Lipper Multiple Myeloma, Institute Physician, Harvard Medical School considers whether isatuximab can remain a treatment option for relapsed/refractory multiple myeloma (MM).

00:01:27

Don

3 years 76 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28729/isatuximab-as-a-treatment-option-for-mm?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28729/isatuximab-as-a-treatment-option-for-mm?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28729/isatuximab-as-a-treatment-option-for-mm?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28729?channelName=obr"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190701184352_0e4c/video_190701184352_0e4c.jpg?cache=15660532861678829655">Isatuximab as a Treatment Option for MM</a>

Link (BBCode):

[url=https://oncologytube.com/v/28729?channelName=obr][img]https://oncologytubecom.cdn.ypt.me/videos/video_190701184352_0e4c/video_190701184352_0e4c.jpg?cache=15660532861678829655[/img]Isatuximab as a Treatment Option for MM[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Acute Lymphoblastic Leukemia

Description:

Paul Richardson, MD, Clinical Program Leader, Director of Clinical Research, Jerome Lipper Multiple Myeloma, Institute Physician, Harvard Medical School considers whether isatuximab can remain a treatment option for relapsed/refractory multiple myeloma (MM).